Join Dr. Deb Berman, assistant dean for admissions, and Carol Teener, director of admissions, along with two current medical students from the University of Michigan Medical School for answers to your questions about getting into medical school and more. The conversation ranges from GPAs and personal statements to the culture and experiences that make Michigan unique.

Experts in brain cancer outline current discoveries and offer a path of hope for glioblastoma treatment

A new urine-based test addresses a major problem in prostate cancer: how to separate the slow growing form of the disease unlikely to cause harm from more aggressive cancer that needs immediate treatment.

Researchers recently revealed a new mechanism behind antiphospholipid syndrome that the investigators hope will eventually allow treatments to be targeted closer to the source of the problem.

Telehealth study of patient portal e-visits by Medicare participants shows few had an interaction for which their provider billed them.

At-home test can detect tumor DNA fragments in urine samples, providing a non-invasive alternative to traditional blood-based biomarker tests

New website to help adolescents with disabilities learn about reproductive health.

Known as the Health Equity Literature Archive, Chelsea Fisk’s goal was to cultivate empathy and understanding for people from different backgrounds and diverse identities by providing employees with access to diverse literature. The innovative pilot led by clinical researcher Chelsea Fisk served as a form of DEI education that was free to use, self-paced and barrier-free.

Cases of kidney stones in children are increasing, but parents can minimize the chances their kids develop them.

The Healthcare Equity Consult Service addresses the concern of bias and discriminations in health care access, delivery, and experience for University of Michigan-Health.

As guest editor for a themed journal issue, Lori Pierce helps highlight the multiple factors that can make cancer care and prevention more equitable and reduce the burden of this disease for all

Vaccination against the coronavirus was much lower in adults and children with sickle cell disease despite a higher risk of severe COVID-19.

Research from Michigan Medicine experts is shedding light and potentially expanding options for patients living with an aggressive childhood cancer.

Recently approved by the Food and Drug Administration, Pluvicto is a radionuclide-labelled drug administered to patients showing promising results.